when did semaglutide hit the market GLP-1 Drugs Size to USD 132.79 Bn by 2035 In the Weight-Loss Wars, Novo's

Semaglutide mimics the GLP-1 hormone, while tirzepatide works on both GLP-1 and GIP pathways to support appetite control, blood sugar balance, and weight loss

Jia et al

Unlike the fixed-schedule approach of mass-market telehealth, compounded formulations enable providers to match dose increments to individual tolerability and response patterns, which may be particularly beneficial for patients with genetic predispositions indicating slower GLP-1 receptor activity or heightened sensitivity to gastrointestinal side effects

pmid:20890901

Bcoz these guys have already started/completed clinical trials in India for Sema

For fat loss specifically, HGH tends to have the upper hand, especially when used in combination with a healthy diet and exercise regimen